.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020548

« Back to Dashboard
NDA 020548 describes FLOVENT, which is a drug marketed by Glaxosmithkline and Glaxo Grp Ltd and is included in four NDAs. There are sixteen patents protecting this drug. Additional details are available on the FLOVENT profile page.

The generic ingredient in FLOVENT is fluticasone propionate. There are twenty-two drug master file entries for this compound. Sixty-eight suppliers are listed for this compound. Additional details are available on the fluticasone propionate profile page.

Summary for NDA: 020548

Tradename:
FLOVENT
Applicant:
Glaxosmithkline
Ingredient:
fluticasone propionate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Respiratory Tract Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:AEROSOL, METERED;INHALATIONStrength0.044MG/INH
Approval Date:Mar 27, 1996TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:AEROSOL, METERED;INHALATIONStrength0.11MG/INH
Approval Date:Mar 27, 1996TE:RLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:AEROSOL, METERED;INHALATIONStrength0.22MG/INH
Approval Date:Mar 27, 1996TE:RLD:No

Expired Orange Book Patents for NDA: 020548

These historical archives are available as an add-on to one-year subscriptions.
See the Subscription Options for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline
FLOVENT
fluticasone propionate
AEROSOL, METERED;INHALATION020548-001Mar 27, 19964,335,121*PED► subscribe
Glaxosmithkline
FLOVENT
fluticasone propionate
AEROSOL, METERED;INHALATION020548-003Mar 27, 19964,335,121*PED► subscribe
Glaxosmithkline
FLOVENT
fluticasone propionate
AEROSOL, METERED;INHALATION020548-002Mar 27, 19964,335,121*PED► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc